Claire Thomas

Claire Thomas

Directeur/Bestuurslid bij REBUS HOLDINGS, INC.

Vermogen: - $ op 31-12-2023

68 jaar
Health Technology
Consumer Services
Commercial Services

Oorsprong van het eerstegraads netwerk van Claire Thomas

EntiteitType entiteitIndustrie
20
Subsidiary Pharmaceuticals: Major 20
Public Company Biotechnology 13
Public Company Pharmaceuticals: Major 11
7
Subsidiary Miscellaneous Commercial Services 7

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Claire Thomas via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Investment Managers

Hiromichi Kimura

Ryosuke Munakata

Hikaru Saito

Satoshi Konagai

Nobuaki Shindoh

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Chief Investment Officer

PFIZER, INC. Pharmaceuticals: Major

Antonio Gualberto

Ronald Shazer

Santhosh Palani

Richard Buller

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Marsha Fanucci

Jacquelyn Sandell

Lisa von Moltke

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

University of Pennsylvania Medical Center College/University

Nancy Simonian

Daniel Curran

Susan Moran

Doctorate Degree

Doctorate Degree

Graduate Degree

SYROS PHARMACEUTICALS, INC. Biotechnology

Marsha Fanucci

Nancy Simonian

Kyle Kuvalanka

Director/Board Member

Chief Executive Officer

Director of Finance/CFO

College/University

Etsuko Okajima

Jerald Korn

Masters Business Admin

Undergraduate Degree

Biotechnology

Hikaru Saito

Satoshi Konagai

Director/Board Member

Director/Board Member

The University of Chicago College/University

Jeffrey Leiden

Matthew B. Boxer

Doctorate Degree

Doctorate Degree

Keio University College/University

Ryosuke Munakata

Nobuaki Shindoh

Doctorate Degree

Graduate Degree

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Jeffrey Leiden

Manisha Pai

Chairman

Public Communications Contact

TAKEDA PHARMACEUTICAL COMPANY LIMITED Pharmaceuticals: Major

Hiromichi Kimura

Daniel Curran

Corporate Officer/Principal

Corporate Officer/Principal

University of Tokyo College/University

Masafumi Nogimori

Hiromichi Kimura

Undergraduate Degree

Doctorate Degree

Harvard Medical School College/University

Jeffrey Leiden

Nancy Simonian

Corporate Officer/Principal

Corporate Officer/Principal

Packaged Software

Jeffrey Leiden

Carl Gordon

Chairman

Director/Board Member

EXELIXIS, INC. Pharmaceuticals: Major

Ronald Shazer

Richard Buller

Corporate Officer/Principal

Corporate Officer/Principal

ALKERMES PLC Pharmaceuticals: Major

Lisa von Moltke

Kathleen Ford

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Jeffrey Leiden

Nancy Simonian

Director/Board Member

Director/Board Member

College/University

Tariq Kassum

Peter E. Grebow

Undergraduate Degree

Undergraduate Degree

Wesleyan University College/University

Kyle Kuvalanka

Anthony Boral

Undergraduate Degree

Undergraduate Degree

BLUEPRINT MEDICINES CORPORATION Biotechnology

Kyle Kuvalanka

Anthony Boral

Director of Finance/CFO

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Kyle Kuvalanka

Daniel Curran

Masters Business Admin

Masters Business Admin

Boston University School of Law College/University

Jacquelyn Sandell

Jerald Korn

Graduate Degree

Graduate Degree

University of Pennsylvania College/University

Santhosh Palani

Yaping Shou

Doctorate Degree

Doctorate Degree

College/University

Jacquelyn Sandell

Susan Moran

Undergraduate Degree

Undergraduate Degree

University of Vermont College/University

David J. Maloney

Matthew B. Boxer

Undergraduate Degree

Undergraduate Degree

AMGEN INC. Pharmaceuticals: Major

Martha E. Vincent

Oliver Rosen

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

KURA ONCOLOGY, INC. Biotechnology

Antonio Gualberto

Kathleen Ford

Founder

Chief Operating Officer

Pharmaceuticals: Major

David J. Maloney

Matthew B. Boxer

Founder

Founder

University of Virginia College/University

David J. Maloney

Susan Moran

Doctorate Degree

Undergraduate Degree

EPIZYME, INC. Biotechnology

Manisha Pai

Jerald Korn

Investor Relations Contact

Chief Operating Officer

Pharmaceuticals: Major

Daniel Curran

Director/Board Member

Personnel Services

Etsuko Okajima

Founder

Miscellaneous Commercial Services

Hiromichi Kimura

President

Chemicals: Agricultural

Hiromichi Kimura

President

EUGLENA CO., LTD. Pharmaceuticals: Other

Etsuko Okajima

Director/Board Member

University of Tsukuba College/University

Etsuko Okajima

Undergraduate Degree

Investment Managers

Etsuko Okajima

President

Miscellaneous Commercial Services

Hiromichi Kimura

President

Biotechnology

Hiromichi Kimura

Director/Board Member

KAMAKURA SHINSHO, LTD. Commercial Printing/Forms

Noriyuki Uematsu

Director/Board Member

LINK AND MOTIVATION INC. Personnel Services

Etsuko Okajima

Director/Board Member

Biotechnology

Hiromichi Kimura

Director/Board Member

SEPTENI HOLDINGS CO., LTD. Advertising/Marketing Services

Etsuko Okajima

Director/Board Member

Miscellaneous Commercial Services

Hiromichi Kimura

Director/Board Member

BLUEBIRD BIO, INC. Biotechnology

Manisha Pai

Investor Relations Contact

Biotechnology

Daniel Curran

Director/Board Member

Miscellaneous Commercial Services

Daniel Curran

Director/Board Member

Miscellaneous Commercial Services

Noriyuki Uematsu

Comptroller/Controller/Auditor

MARUI GROUP CO., LTD. Finance/Rental/Leasing

Etsuko Okajima

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 30
Japan 20
Ierland 2
Verenigd Koninkrijk 2

Sectoraal

Health Technology 21
Consumer Services 16
Commercial Services 11
Finance 4
Technology Services 2

Operationeel

Director/Board Member 198
Corporate Officer/Principal 95
Independent Dir/Board Member 68
Chief Tech/Sci/R&D Officer 36
Undergraduate Degree 33
  1. Beurs
  2. Insiders
  3. Claire Thomas
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU